Felicetti F - Search Results

1

SCD5-induced oleic acid production reduces melanoma malignancy by intracellular retention of SPARC and cathepsin B.

Bellenghi M, Puglisi R, Pedini F, De Feo A, Felicetti F, Bottero L, Sangaletti S, Errico MC, Petrini M, Gesumundo C, Denaro M, Felli N, Pasquini L, Tripodo C, Colombo MP, Carè A, Mattia G. Bellenghi M, et al. Among authors: felicetti f. J Pathol. 2015 Jul;236(3):315-25. doi: 10.1002/path.4535. Epub 2015 Apr 20. J Pathol. 2015. PMID: 25802234

2

Enforced expression of HOXB7 promotes hematopoietic stem cell proliferation and myeloid-restricted progenitor differentiation.

Carè A, Valtieri M, Mattia G, Meccia E, Masella B, Luchetti L, Felicetti F, Colombo MP, Peschle C. Carè A, et al. Among authors: felicetti f. Oncogene. 1999 Mar 18;18(11):1993-2001. doi: 10.1038/sj.onc.1202498. Oncogene. 1999. PMID: 10208421

3

HOXB7: a key factor for tumor-associated angiogenic switch.

Carè A, Felicetti F, Meccia E, Bottero L, Parenza M, Stoppacciaro A, Peschle C, Colombo MP. Carè A, et al. Among authors: felicetti f. Cancer Res. 2001 Sep 1;61(17):6532-9. Cancer Res. 2001. PMID: 11522651

4

HOXB7 expression is regulated by the transcription factors NF-Y, YY1, Sp1 and USF-1.

Meccia E, Bottero L, Felicetti F, Peschle C, Colombo MP, Carè A. Meccia E, et al. Among authors: felicetti f. Biochim Biophys Acta. 2003 Apr 15;1626(1-3):1-9. doi: 10.1016/s0167-4781(03)00018-6. Biochim Biophys Acta. 2003. PMID: 12697323

5

Angiopoietin decoy secreted at tumor site impairs tumor growth and metastases by inducing local inflammation and altering neoangiogenesis.

Melani C, Stoppacciaro A, Foroni C, Felicetti F, Caré A, Colombo MP. Melani C, et al. Among authors: felicetti f. Cancer Immunol Immunother. 2004 Jul;53(7):600-8. doi: 10.1007/s00262-004-0500-5. Epub 2004 Feb 25. Cancer Immunol Immunother. 2004. PMID: 14985859 Free PMC article.

6

Role of PLZF in melanoma progression.

Felicetti F, Bottero L, Felli N, Mattia G, Labbaye C, Alvino E, Peschle C, Colombo MP, Carè A. Felicetti F, et al. Oncogene. 2004 Jun 3;23(26):4567-76. doi: 10.1038/sj.onc.1207597. Oncogene. 2004. PMID: 15077196

7

The promyelocytic leukemia zinc finger-microRNA-221/-222 pathway controls melanoma progression through multiple oncogenic mechanisms.

Felicetti F, Errico MC, Bottero L, Segnalini P, Stoppacciaro A, Biffoni M, Felli N, Mattia G, Petrini M, Colombo MP, Peschle C, Carè A. Felicetti F, et al. Cancer Res. 2008 Apr 15;68(8):2745-54. doi: 10.1158/0008-5472.CAN-07-2538. Cancer Res. 2008. PMID: 18417445

8

MicroRNA-221 and -222 pathway controls melanoma progression.

Felicetti F, Errico MC, Segnalini P, Mattia G, Carè A. Felicetti F, et al. Expert Rev Anticancer Ther. 2008 Nov;8(11):1759-65. doi: 10.1586/14737140.8.11.1759. Expert Rev Anticancer Ther. 2008. PMID: 18983236 Review.

9

Caveolin-1 tumor-promoting role in human melanoma.

Felicetti F, Parolini I, Bottero L, Fecchi K, Errico MC, Raggi C, Biffoni M, Spadaro F, Lisanti MP, Sargiacomo M, Carè A. Felicetti F, et al. Int J Cancer. 2009 Oct 1;125(7):1514-22. doi: 10.1002/ijc.24451. Int J Cancer. 2009. PMID: 19521982 Free PMC article.

10

Human melanoma cells express FGFR/Src/Rho signaling that entails an adhesion-independent caveolin-1 membrane association.

Fecchi K, Travaglione S, Spadaro F, Quattrini A, Parolini I, Piccaro G, Raggi C, Fabbri A, Felicetti F, Carè A, Fiorentini C, Sargiacomo M. Fecchi K, et al. Among authors: felicetti f. Int J Cancer. 2012 Mar 15;130(6):1273-83. doi: 10.1002/ijc.26092. Epub 2011 May 25. Int J Cancer. 2012. PMID: 21445970

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

69 results

Search Page

Filters